1 | Title |
2 |
Principal Investigators, Co-Investigators and Supervisors where applicable -Their addresses and signatures should be included -Role of investigators/supervisors as applicable -The committee may require their curriculum vitae |
3 | Any collaborating institution(s) |
4 |
Funding agency where applicable -The committee may require their curriculum vitae |
5 | List of abbreviations and acronyms |
6 | Operational definitions |
7 | Table of contents |
8 | Structured summary (Approximately 200-300 words) |
9 | Introduction/background |
10 |
Literature review including conceptual/theoretical framework |
11 | Rationale/ Study justification |
12 |
Study questions, hypothesis where applicable
|
13 |
Objectives/Aims: a. Broad objective(s)/overall goals b. Specific objectives c. Secondary objectives if applicable |
14 |
Methodology: a. Study design b. Study area description -Specific study site c. Study population -Population characteristics -Definition of cases/controls if applicable -Inclusion/exclusion criteria d. Sample size determination and formula/computer programme used (assumptions and reference) e. Sampling procedure/screening/selection of study participants f. Recruitment and consenting procedures g. Variables – dependent, independent, confounders where applicable h. Data collection procedures (qualitative and quantitative data, field data collection instruments, laboratory procedures etc) i. Materials – equipment, supplies etc j. Training procedures where applicable k. Quality assurance procedures |
15 | Ethical consideration-briefly explain the ethical issues that may be associated with the study and strategies to address them |
16 | Data management (data entry, cleaning, storage, security and quality assurance, statistical analysis plans etc.) |
17 | Study results dissemination plan |
18 | Study limitations and how to minimize them |
19 | Study timeline/time frame |
20 | Study closure plan and procedure |
21 |
References - Use internationally accepted format e.g. Vancouver, Harvard, American Psychological Association (APA) etc. must maintain format consistency |
22 |
Budget and budget justification -Consider coverage of such areas as Personnel, Salaries and Salary disbursements, Training costs, Participants service costs, Supplies and equipment, Animal acquisition where applicable, Travel and accommodation, Transport – vehicles – repair, fuel, Operating expenses – postage, report writing etc., Consultancy if applicable, Dissemination, Miscellaneous, Contingency (%) |
23 |
Appendices for example: A. Informed Consent/ Assent Explanation and Consent Form
(Click for the consent explanation template)II) Consent form to include investigators and participant statement with signature page (Click for consent form template) |
B. Study instruments/tools | |
C. Curriculum vitae where applicable | |
D. Reference procedures/ brochures etc. where applicable | |
E. Maps where applicable | |
F. Special information e.g. educational/publicity materials | |
G. Any other relevant information according to the study | |
More information to researchers 1. Severe Adverse Events (SAE) should be reported to the KNH-UoN ERC within 72 hours as per the approved format. 2.Protocol violations/deviations should be reported to KNH-UoN ERC as soon as they occur. 3.KNH-UoN ERC approval is required for transfer of materials from one laboratory to another for analysis. (Click for the transfer of materials form) 4.The KNH-UoN ERC approval is given for one year only. The researcher is required to officially request for renewal at least 60 days to the expiry of the current approval and provide a detailed progress report for the preceding year. 5. KNH-UoN ERC will make study site visits as and when deemed necessary. 6. The Principal Investigator must provide the executive study summary and a list of publications to KNH-UoN ERC of the at the end of study. 7. The Principal Investigator must provide study closure report if the study ceases to continue for whatever reason. |
|
Expiry Date